{
  "items": "27",
  "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
  "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
  "feed": [
    {
      "title": "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Waldencast plc (WALD) and Encourages Investors to Learn More About the Investigation",
      "url": "https://fox59.com/business/press-releases/accesswire/1118712/bronstein-gewirtz-grossman-llc-announces-an-investigation-against-waldencast-plc-wald-and-encourages-investors-to-learn-more-about-the-investigation",
      "time_published": "20251226T140907",
      "authors": [
        "NULL"
      ],
      "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Waldencast plc (NASDAQ:WALD) following the company's Q2 2025 financial results. Waldencast updated its full-year 2025 financial outlook, forecasting net revenue broadly in line with 2024 and an adjusted EBITDA margin in the high single digits, a significant reduction from previous guidance. The company also reported a net loss of $185.2 million for H1 2025, driven by impairment charges on its Obagi Medical and Milk Makeup brands, which led to a 6.49% drop in its Class A ordinary share price.",
      "banner_image": "https://app.accessnewswire.com/img.ashx?id=1118712",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.917069"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.824173"
        },
        {
          "topic": "finance",
          "relevance_score": "0.736545"
        }
      ],
      "overall_sentiment_score": -0.749104,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.721844",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Waldencast plc (WALD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation",
      "url": "https://fox59.com/business/press-releases/accesswire/1118711/waldencast-plc-wald-investigation-bronstein-gewirtz-grossman-llc-encourages-shareholders-to-contact-the-firm-to-learn-more-about-the-investigation",
      "time_published": "20251225T160857",
      "authors": [
        "NULL"
      ],
      "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Waldencast plc (NASDAQ:WALD) following a significant drop in its Class A ordinary share price. This decline occurred after the company updated its 2025 financial outlook, projecting lower revenue growth and EBITDA margins than previously guided, and reported substantial net losses due to impairment charges on its brands. Investors who purchased Waldencast securities are encouraged to contact the firm for more information regarding the investigation.",
      "banner_image": "https://nxstrib.com/wp-content/uploads/2022/10/ANW_COLOR_FULL_VECTOR.png?w=300",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.947477"
        },
        {
          "topic": "finance",
          "relevance_score": "0.816380"
        }
      ],
      "overall_sentiment_score": -0.644015,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.628251",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Bronstein, Gewirtz & Grossman, LLC Is Investigating Waldencast plc (WALD) And Encourages Investors to Connect",
      "url": "https://fox59.com/business/press-releases/accesswire/1118710/bronstein-gewirtz-grossman-llc-is-investigating-waldencast-plc-wald-and-encourages-investors-to-connect",
      "time_published": "20251224T160930",
      "authors": [
        "NULL"
      ],
      "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Waldencast plc (NASDAQ: WALD) on behalf of investors. This investigation follows Waldencast's revised 2025 financial outlook, which significantly reduced revenue growth and EBITDA margin expectations, along with reported net losses and impairment charges for its Obagi Medical and Milk Makeup brands. The firm encourages affected investors to contact them to assist in the investigation.",
      "banner_image": "https://app.accessnewswire.com/img.ashx?id=1118710",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "1.000000"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.841740"
        }
      ],
      "overall_sentiment_score": -0.614694,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.638659",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD",
      "url": "https://fox59.com/business/press-releases/accesswire/1119121/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-waldencast-plc-wald",
      "time_published": "20251224T150930",
      "authors": [
        "NULL"
      ],
      "summary": "Pomerantz LLP is investigating potential securities fraud claims against Waldencast plc (NASDAQ: WALD) on behalf of investors. This investigation follows a significant drop in Waldencast's share price after the company updated its financial outlook for 2025, lowering revenue growth and EBITDA margin expectations, and reported substantial impairment charges for its Obagi Medical and Milk Makeup brands. Investors who believe they have been affected are encouraged to contact the law firm for more information.",
      "banner_image": "https://app.accessnewswire.com/img.ashx?id=1119121",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "0.914852"
        }
      ],
      "overall_sentiment_score": -0.747054,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.741671",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Waldencast plc (WALD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation",
      "url": "https://fox59.com/business/press-releases/accesswire/1118706/waldencast-plc-wald-investigation-bronstein-gewirtz-grossman-llc-encourages-stockholders-to-contact-the-firm-to-learn-more-about-the-investigation",
      "time_published": "20251220T151056",
      "authors": [
        "NULL"
      ],
      "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Waldencast plc (NASDAQ:WALD) after the company updated its financial outlook for 2025, significantly lowering its revenue growth and EBITDA margin expectations. This update, along with reported impairment charges on its Obagi Medical and Milk Makeup brands, led to a drop in Waldencast's share price. The firm is encouraging stockholders to contact them to learn more about the investigation.",
      "banner_image": "https://app.accessnewswire.com/imagelibrary/a7af43b2-7621-48bf-b6f1-d41b655ada4a/1118706/bronsteinlogonew.jpg",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.927892"
        },
        {
          "topic": "finance",
          "relevance_score": "0.840678"
        }
      ],
      "overall_sentiment_score": -0.431193,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.417831",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD",
      "url": "https://wreg.com/business/press-releases/accesswire/1118247/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-waldencast-plc-wald",
      "time_published": "20251220T100000",
      "authors": [
        "NULL"
      ],
      "summary": "Pomerantz LLP is investigating potential securities fraud claims against Waldencast plc (NASDAQ: WALD) on behalf of investors. The investigation follows Waldencast's revised financial outlook for 2025, which indicated significantly lower revenue and adjusted EBITDA margin expectations compared to previous guidance, alongside substantial impairment charges on their Obagi Medical and Milk Makeup brands. This news led to an immediate drop in Waldencast's share price.",
      "banner_image": "https://app.accessnewswire.com/img.ashx?id=1118247",
      "source": "WREG.com",
      "category_within_source": "General",
      "source_domain": "WREG.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.915663"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.712782"
        },
        {
          "topic": "finance",
          "relevance_score": "0.621458"
        }
      ],
      "overall_sentiment_score": -0.617007,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.628392",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Waldencast schedules annual meeting and announces board changes By Investing.com",
      "url": "https://m.ng.investing.com/news/sec-filings/waldencast-schedules-annual-meeting-and-announces-board-changes-93CH-2263394?ampMode=1",
      "time_published": "20251220T090930",
      "authors": [
        "Investing.com"
      ],
      "summary": "Waldencast plc announced its 2025 annual general meeting for January 14, 2026, where shareholders will vote on renewing Class III directors. The company also reported board changes, including the resignations of Lindsay Pattison and Zack Werner, and reclassified its remaining directors into three classes. These announcements come after recent disappointing sales results and revised price targets from analysts.",
      "banner_image": "NULL",
      "source": "Investing.com Nigeria",
      "category_within_source": "General",
      "source_domain": "Investing.com Nigeria",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.834892"
        },
        {
          "topic": "finance",
          "relevance_score": "0.714380"
        }
      ],
      "overall_sentiment_score": 0.031971,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "0.309526",
          "ticker_sentiment_score": "0.046204",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD",
      "url": "https://fox59.com/business/press-releases/accesswire/1118245/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-waldencast-plc-wald",
      "time_published": "20251219T150859",
      "authors": [
        "NULL"
      ],
      "summary": "Pomerantz LLP is investigating potential securities fraud claims against Waldencast plc (NASDAQ: WALD) following a significant drop in its share price. This comes after the company updated its 2025 financial outlook, projecting lower revenue growth and adjusted EBITDA margins than previously guided, alongside reporting a net loss driven by substantial impairment charges. Investors are advised to contact Pomerantz LLP for information regarding a potential class action lawsuit.",
      "banner_image": "https://app.accessnewswire.com/img.ashx?id=1118245",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "0.949334"
        }
      ],
      "overall_sentiment_score": -0.825803,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.824708",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Waldencast plc (WALD) and Encourages Stockholders to Learn More About the Investigation",
      "url": "https://fox59.com/business/press-releases/accesswire/1118705/bronstein-gewirtz-grossman-llc-announces-an-investigation-against-waldencast-plc-wald-and-encourages-stockholders-to-learn-more-about-the-investigation",
      "time_published": "20251218T160942",
      "authors": [
        "NULL"
      ],
      "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Waldencast plc (NASDAQ: WALD) following a significant drop in its Class A ordinary share price. This move comes after Waldencast updated its financial outlook for 2025, lowering revenue growth and EBITDA margin guidance and reporting a substantial net loss with impairment charges on its Obagi Medical and Milk Makeup brands. The firm is encouraging investors who purchased Waldencast securities to join the investigation to potentially recover losses.",
      "banner_image": "https://app.accessnewswire.com/imagelibrary/a7af43b2-7621-48bf-b6f1-d41b655ada4a/1118705/bronsteinlogonew.jpg",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.940799"
        },
        {
          "topic": "finance",
          "relevance_score": "0.811410"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.739436"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.633475"
        }
      ],
      "overall_sentiment_score": -0.842819,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.832337",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Bronstein, Gewirtz & Grossman, LLC Encourages Waldencast plc (WALD) Investors to Inquire about Securities Investigation",
      "url": "https://fox59.com/business/press-releases/accesswire/1118704/bronstein-gewirtz-grossman-llc-encourages-waldencast-plc-wald-investors-to-inquire-about-securities-investigation",
      "time_published": "20251217T160849",
      "authors": [
        "NULL"
      ],
      "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Waldencast plc (NASDAQ: WALD) after the company updated its financial outlook for 2025, expecting lower net revenue growth and adjusted EBITDA margin than previously guided. The company also reported a net loss of $185.2 million for the first half of 2025, largely due to significant impairment charges on its Obagi Medical and Milk Makeup brands, causing its share price to drop. Investors are encouraged to contact the firm for more information regarding this securities investigation.",
      "banner_image": "https://app.accessnewswire.com/img.ashx?id=1118704",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.915956"
        },
        {
          "topic": "finance",
          "relevance_score": "0.849578"
        }
      ],
      "overall_sentiment_score": 0.049295,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "0.325394",
          "ticker_sentiment_score": "0.022555",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD",
      "url": "https://www.wdhn.com/business/press-releases/accesswire/1117749/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-waldencast-plc-wald",
      "time_published": "20251217T100000",
      "authors": [
        "NULL"
      ],
      "summary": "Pomerantz LLP is investigating Waldencast plc (NASDAQ: WALD) on behalf of investors regarding potential securities fraud and unlawful business practices. This investigation follows Waldencast's updated full-year 2025 financial outlook, which projected net revenue in line with 2024 and a lower adjusted EBITDA margin, as well as a significant net loss partly due to impairment charges on their Obagi Medical and Milk Makeup brands. The announcement led to a 6.49% drop in Waldencast's Class A ordinary share price.",
      "banner_image": "https://i0.wp.com/www.wdhn.com/wp-content/uploads/sites/33/2025/12/D2B0C066A52C19475285EB619770A4CC.jpg?w=2000&ssl=1",
      "source": "WDHN",
      "category_within_source": "General",
      "source_domain": "WDHN",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.931991"
        },
        {
          "topic": "finance",
          "relevance_score": "0.841383"
        }
      ],
      "overall_sentiment_score": -0.627003,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.639293",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD",
      "url": "https://wreg.com/business/press-releases/accesswire/1117747/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-waldencast-plc-wald",
      "time_published": "20251216T150942",
      "authors": [
        "NULL"
      ],
      "summary": "Pomerantz LLP is investigating Waldencast plc (NASDAQ: WALD) on behalf of investors for potential securities fraud or unlawful business practices. This investigation follows Waldencast's updated financial outlook for 2025, which projected net revenue broadly in line with 2024 and adjusted EBITDA in the high single digits, significantly lower than previous guidance, and a reported net loss of $185.2 million with impairment charges. Consequently, Waldencast's share price dropped by 6.49%.",
      "banner_image": "https://app.accessnewswire.com/img.ashx?id=1117747",
      "source": "WREG.com",
      "category_within_source": "General",
      "source_domain": "WREG.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.904027"
        },
        {
          "topic": "finance",
          "relevance_score": "0.810245"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.742951"
        },
        {
          "topic": "economy_macro",
          "relevance_score": "0.624487"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.641887"
        }
      ],
      "overall_sentiment_score": -0.396561,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.386277",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD",
      "url": "https://cw33.com/business/press-releases/accesswire/1116062/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-waldencast-plc-wald",
      "time_published": "20251213T170926",
      "authors": [
        "NULL"
      ],
      "summary": "Pomerantz LLP is investigating Waldencast plc (NASDAQ: WALD) on behalf of investors regarding potential securities fraud or unlawful business practices. This investigation follows Waldencast's revised financial outlook for 2025, which included lower revenue growth and EBITDA margin guidance, and reported a significant net loss driven by impairment charges on its Obagi Medical and Milk Makeup brands. The announcement led to a 6.49% drop in Waldencast's share price.",
      "banner_image": "https://i0.wp.com/cw33.com/wp-content/uploads/sites/8/2025/12/Photo-Dec-11-2025-10-07-12-AM-1.jpg?w=2000&ssl=1",
      "source": "CW33.com",
      "category_within_source": "General",
      "source_domain": "CW33.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.928002"
        },
        {
          "topic": "finance",
          "relevance_score": "0.845548"
        }
      ],
      "overall_sentiment_score": -0.449741,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.413780",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD",
      "url": "https://fox59.com/business/press-releases/accesswire/1116062/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-waldencast-plc-wald",
      "time_published": "20251213T100000",
      "authors": [
        "NULL"
      ],
      "summary": "Pomerantz LLP is investigating Waldencast plc (NASDAQ: WALD) on behalf of investors regarding potential securities fraud or unlawful business practices. This investigation follows Waldencast's revised 2025 financial outlook, which downgraded revenue growth and EBITDA margin expectations and reported a significant net loss driven by impairment charges on its Obagi Medical and Milk Makeup brands, leading to a stock price drop. Investors are encouraged to contact Pomerantz LLP to inquire about joining a potential class action.",
      "banner_image": "https://app.accessnewswire.com/img.ashx?id=1116062",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "0.821181"
        }
      ],
      "overall_sentiment_score": -0.629922,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.601100",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD",
      "url": "https://fox59.com/business/press-releases/accesswire/1115611/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-waldencast-plc-wald",
      "time_published": "20251210T170957",
      "authors": [],
      "summary": "Pomerantz LLP is investigating potential securities fraud claims against Waldencast plc (NASDAQ: WALD) following a significant drop in its share price. The investigation comes after Waldencast updated its financial outlook for 2025, lowering revenue growth and EBITDA margin expectations, and reporting a substantial net loss driven by impairment charges on its Obagi Medical and Milk Makeup brands. The firm advises affected investors to contact them regarding a potential class action lawsuit.",
      "banner_image": "https://nxstrib.com/wp-content/uploads/2022/10/ANW_COLOR_FULL_VECTOR.png?w=300",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "0.911613"
        }
      ],
      "overall_sentiment_score": -0.426538,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.396661",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD",
      "url": "https://fox59.com/business/press-releases/accesswire/1113846/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-waldencast-plc-wald",
      "time_published": "20251206T180953",
      "authors": [
        "NULL"
      ],
      "summary": "Pomerantz LLP is investigating Waldencast plc (NASDAQ: WALD) on behalf of investors for potential securities fraud or unlawful business practices. This investigation follows Waldencast's revised 2025 financial outlook, which downgraded revenue growth expectations and adjusted EBITDA margin, and reported significant impairment charges on its Obagi Medical and Milk Makeup brands, leading to a stock price drop. Investors are encouraged to contact Pomerantz LLP to inquire about joining the class action.",
      "banner_image": "https://app.accessnewswire.com/img.ashx?id=1113846",
      "source": "Fox 59",
      "category_within_source": "General",
      "source_domain": "Fox 59",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.920247"
        },
        {
          "topic": "finance",
          "relevance_score": "0.727525"
        }
      ],
      "overall_sentiment_score": -0.429995,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.410888",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Revenues Tell The Story For Waldencast plc (NASDAQ:WALD) As Its Stock Soars 33%",
      "url": "https://www.sahmcapital.com/news/content/revenues-tell-the-story-for-waldencast-plc-nasdaqwald-as-its-stock-soars-33-2025-11-26",
      "time_published": "20251125T180943",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Waldencast plc (NASDAQ:WALD) shares have risen 33% in the last month, though they are still down 22% over the last year. Despite the recent jump, its price-to-sales (P/S) ratio of 1.1x is similar to the industry median, indicating that investors might be overlooking specific factors. The company's recent revenue growth has been positive compared to declining industry trends, with analysts forecasting a 4.6% increase in revenue for the coming year, aligning its P/S ratio with industry peers.",
      "banner_image": "https://images.simplywall.st/asset/chart/705209892-ps-multiple-vs-industry-1-dark-2/1764152975200",
      "source": "Sahm",
      "category_within_source": "General",
      "source_domain": "Sahm",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.923182"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.832805"
        },
        {
          "topic": "finance",
          "relevance_score": "0.727866"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.632612"
        }
      ],
      "overall_sentiment_score": 0.133371,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "0.971276",
          "ticker_sentiment_score": "0.149991",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Waldencast plc Sells Obagi Trademark Rights in Japan to Rohto Pharmaceutical for $82.5 Million",
      "url": "https://www.quiverquant.com/news/Waldencast+plc+Sells+Obagi+Trademark+Rights+in+Japan+to+Rohto+Pharmaceutical+for+%2482.5+Million",
      "time_published": "20251114T101100",
      "authors": [
        "NULL"
      ],
      "summary": "Waldencast plc announced the sale of its \"Obagi\" trademark rights in Japan to Rohto Pharmaceutical Co., Ltd. for $82.5 million, a strategic move to strengthen its balance sheet. This comes after Rohto successfully licensed the brand since 2002 without overlap with the global Obagi Medical brand. Concurrently, Waldencast secured a new $225 million credit agreement with Lumina Capital Management to enhance liquidity, with a significant portion of the trademark sale proceeds intended to repay this new loan and maximize shareholder value.",
      "banner_image": "https://www.quiverquant.com/images/wald_rect_new.png",
      "source": "Quiver Quantitative",
      "category_within_source": "General",
      "source_domain": "Quiver Quantitative",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.941665"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.836500"
        },
        {
          "topic": "finance",
          "relevance_score": "0.700485"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.628185"
        }
      ],
      "overall_sentiment_score": 0.2982,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.272058",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Waldencast PLC (NASDAQ:WALD) Receives Consensus Rating of \"Moderate Buy\" from Analysts - MarketBeat",
      "url": "https://www.marketbeat.com/instant-alerts/waldencast-plc-nasdaqwald-receives-consensus-rating-of-moderate-buy-from-analysts-2025-10-14/",
      "time_published": "20251014T081531",
      "authors": [
        "MarketBeat"
      ],
      "summary": "Waldencast PLC (NASDAQ:WALD) has received a consensus rating of \"Moderate Buy\" from analysts, with an average one-year price target of $4.9714. The company's stock recently traded up 1.1%, and institutional investors have been adjusting their positions. Waldencast operates in the beauty and wellness business, developing and acquiring various brands including Obagi Medical.",
      "banner_image": "https://www.marketbeat.com/logos/waldencast-plc-logo-1200x675.png?v=20221205135324",
      "source": "MarketBeat",
      "category_within_source": "General",
      "source_domain": "MarketBeat",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "1.000000"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.706500"
        },
        {
          "topic": "finance",
          "relevance_score": "0.630970"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.509101"
        }
      ],
      "overall_sentiment_score": 0.047613,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "0.313317",
          "ticker_sentiment_score": "0.046218",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast",
      "url": "https://www.infosalus.com/comunicados/noticia-comunicado-croma-pharma-gmbh-announces-strategic-milestone-as-novaestiq-corp-joins-waldencast-20250723161726.html",
      "time_published": "20250723T161700",
      "authors": [
        "Infosalus"
      ],
      "summary": "Croma-Pharma GmbH announced the acquisition of Novaestiq Corp. by Waldencast plc, a move that will bring Saypha injectable hyaluronic acid gels to the U.S. market under the Obagi Medical brand. This strategic milestone is part of Croma-Pharma's international growth strategy, expanding the global reach of its science-driven aesthetic solutions. The Saypha products are currently undergoing the FDA approval process, supported by robust clinical studies.",
      "banner_image": null,
      "source": "Infosalus",
      "category_within_source": "General",
      "source_domain": "Infosalus",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.808981"
        },
        {
          "topic": "finance",
          "relevance_score": "0.410715"
        }
      ],
      "overall_sentiment_score": 0.037116,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "0.329487",
          "ticker_sentiment_score": "0.037585",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "It's Down 29% But Waldencast plc (NASDAQ:WALD) Could Be Riskier Than It Looks",
      "url": "https://www.sahmcapital.com/news/content/its-down-29-but-waldencast-plc-nasdaqwald-could-be-riskier-than-it-looks-2025-04-09",
      "time_published": "20250409T045226",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Waldencast plc's stock has dropped 29% in the last month, contributing to a 63% loss over the past year. Despite its current price-to-sales ratio being in line with the industry, the market may be pricing in risks not reflected in its strong revenue growth and positive analyst forecasts. Investors are advised to consider the potential future revenue volatility.",
      "banner_image": "https://images.simplywall.st/asset/chart/705209892-ps-multiple-vs-industry-1-dark/1744194254618",
      "source": "Sahm",
      "category_within_source": "General",
      "source_domain": "Sahm",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.936824"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.819820"
        }
      ],
      "overall_sentiment_score": -0.238217,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.224478",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Obagi Medical Announces the Launch of ELASTIDERM\u00ae Lift Up & Sculpt Facial Moisturizer and ELASTIDERM\u00ae Advanced Filler Concentrate",
      "url": "https://www.globenewswire.com/news-release/2024/09/09/2942930/0/en/Obagi-Medical-Announces-the-Launch-of-ELASTIDERM-Lift-Up-Sculpt-Facial-Moisturizer-and-ELASTIDERM-Advanced-Filler-Concentrate.html",
      "time_published": "20240909T093700",
      "authors": [],
      "summary": "Obagi Medical has launched two new ELASTIDERM\u00ae products: Lift Up & Sculpt Facial Moisturizer and Advanced Filler Concentrate. These products leverage cutting-edge technology and advanced formulations, including Obagi's patented Bi-Mineral Contour Complex\u2122 and Acetyl Hexapeptide-1, to address signs of aging by enhancing skin elasticity, hydration, and reducing the appearance of fine lines and wrinkles. The new offerings are designed to complement professional anti-aging treatments and provide effective at-home skincare solutions.",
      "banner_image": "https://www.globenewswire.com/NewsRoom/AttachmentNg/798b5c0e-14fc-4953-a72e-1d23eb42fe26",
      "source": "GlobeNewswire",
      "category_within_source": "General",
      "source_domain": "GlobeNewswire",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.923088"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.723670"
        }
      ],
      "overall_sentiment_score": 0.454728,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.493774",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops\u00ae Rejuvenating Eye Gel Cream",
      "url": "https://www.globenewswire.com/news-release/2024/03/07/2842312/0/en/Obagi-Cosmeceuticals-Announces-the-Launch-of-Daily-Hydro-Drops-Rejuvenating-Eye-Gel-Cream.html",
      "time_published": "20240307T090000",
      "authors": [],
      "summary": "Obagi Cosmeceuticals has launched the Daily Hydro-Drops\u00ae Rejuvenating Eye Gel Cream, the latest addition to its bestselling Daily Hydro-Drops\u00ae collection. This new product is designed to provide 24-hour lasting hydration and address concerns like dryness, dark circles, and puffiness around the delicate eye area. It features clinically proven moisturizers, oils, brighteners, antioxidants, and is formulated with Isoplentix\u00ae technology for optimal ingredient preservation and release.",
      "banner_image": "https://www.globenewswire.com/NewsRoom/AttachmentNg/e7c231d6-54b0-476b-b6fb-94b7fc795868",
      "source": "GlobeNewswire",
      "category_within_source": "General",
      "source_domain": "GlobeNewswire",
      "topics": [
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.843866"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.732147"
        },
        {
          "topic": "finance",
          "relevance_score": "0.645898"
        }
      ],
      "overall_sentiment_score": 0.412997,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.425672",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Waldencast Appoints Mazdack Rassi To Lead Newly Established Creative Council",
      "url": "https://www.happi.com/breaking-news/waldencast-appoints-mazdack-rassi-global-brand-dir/",
      "time_published": "20240222T000000",
      "authors": [
        "Lianna Albrizio"
      ],
      "summary": "Waldencast, a global multi-brand beauty and wellness platform, has established a new creative council to stay ahead of industry trends and meet evolving customer needs. The council will be led by Mazdack Rassi, Co-Founder and chief brand officer at Milk Makeup and newly-appointed Global Brand Director at Waldencast. Its members include other industry leaders from beauty, retail, design, and branding.",
      "banner_image": null,
      "source": "Happi | Household And Personal Products Industry",
      "category_within_source": "General",
      "source_domain": "Happi | Household And Personal Products Industry",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.736753"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.826268"
        }
      ],
      "overall_sentiment_score": 0.626585,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.635929",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Waldencast Names Manuel Manfredi as CFO",
      "url": "https://www.citybiz.co/article/515704/waldencast-names-manuel-manfredi-as-cfo/",
      "time_published": "20240131T000000",
      "authors": [],
      "summary": "Waldencast plc announced the appointment of Manuel Manfredi as its new Chief Financial Officer, effective April 1, 2024. Manfredi brings nearly 25 years of financial leadership experience in the beauty and consumer products industries, most recently serving as CFO for L\u2019Or\u00e9al Spain and Portugal. Michel Brousset, Waldencast's CEO, will act as interim CFO until Manfredi's start date, succeeding Philippe Gautier who is departing the company.",
      "banner_image": null,
      "source": "citybiz",
      "category_within_source": "General",
      "source_domain": "citybiz",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.843927"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.648028"
        }
      ],
      "overall_sentiment_score": 0.345942,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.335554",
          "ticker_sentiment_label": "Somewhat-Bullish"
        },
        {
          "ticker": "PG",
          "relevance_score": "0.646967",
          "ticker_sentiment_score": "0.340452",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "WALD, WALDW INVESTOR NEWS: ROSEN, A LEADING LAW FIRM, Encourages Waldencast plc Investors With Losses to Inquire About Securities Class Action Investigation \u2013 WALD, WALDW",
      "url": "https://www.businesswire.com/news/home/20230815911653/en/WALD-WALDW-INVESTOR-NEWS-ROSEN-A-LEADING-LAW-FIRM-Encourages-Waldencast-plc-Investors-With-Losses-to-Inquire-About-Securities-Class-Action-Investigation-WALD-WALDW",
      "time_published": "20230815T180953",
      "authors": [
        "NULL"
      ],
      "summary": "Rosen Law Firm is investigating potential securities claims against Waldencast PLC (Nasdaq: WALD, WALDW) due to allegations that the company issued materially misleading business information. This investigation follows a disclosure by Waldencast on July 5, 2023, stating that certain financial statements of its acquired company, Obagi, could no longer be relied upon and needed restatement, causing a 10.2% drop in stock price. Investors who purchased Waldencast securities are encouraged to inquire about joining a prospective class action to recover losses.",
      "banner_image": "NULL",
      "source": "Business Wire",
      "category_within_source": "General",
      "source_domain": "Business Wire",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.825185"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.700062"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.642243"
        }
      ],
      "overall_sentiment_score": -0.469976,
      "overall_sentiment_label": "Bearish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "-0.475534",
          "ticker_sentiment_label": "Bearish"
        }
      ]
    },
    {
      "title": "Waldencast Plc Reports Net Sales of $78.9 Million in Q3",
      "url": "https://www.happi.com/breaking-news/waldencast-plc-report-net-sales-of-78-9-million-in/",
      "time_published": "20221110T191601",
      "authors": [
        "Lianna Albrizio"
      ],
      "summary": "Waldencast Plc reported net sales of $78.9 million in Q3 2022, driven by strong performances from its Milk Makeup and Obagi brands. Obagi Skincare saw sales of $60.4 million (up 3.2%), while Milk Makeup achieved $18.5 million in sales (up 41.7%). The company recorded a gross margin of 62.4% and an adjusted EBITDA of $15.3 million, reaffirming its guidance for the year.",
      "banner_image": null,
      "source": "Happi | Household And Personal Products Industry",
      "category_within_source": "General",
      "source_domain": "Happi | Household And Personal Products Industry",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.937161"
        },
        {
          "topic": "retail_wholesale",
          "relevance_score": "0.800544"
        },
        {
          "topic": "finance",
          "relevance_score": "0.603534"
        }
      ],
      "overall_sentiment_score": 0.445189,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "WALD",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.400383",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    }
  ]
}